Transdiagnostic O
Effects O
of O
Ventromedial O
Prefrontal O
Cortex O
Transcranial O
Magnetic O
Stimulation O
on O
Cue O
Reactivity O
BACKGROUND O
: O
Elevated O
frontal O
and O
striatal O
reactivity O
to O
drug O
cues O
is O
a O
transdiagnostic O
hallmark O
of O
substance O
use O
disorders O
. O

The O
goal O
of O
these O
experiments O
was O
to O
determine O
if O
it O
is O
possible O
to O
decrease O
frontal O
and O
striatal O
reactivity O
to O
drug O
cues O
in O
both O
cocaine O
users O
and O
heavy O
alcohol O
users O
through O
continuous O
theta O
burst O
stimulation O
( O
cTBS O
) O
to O
the O
left O
ventromedial O
prefrontal O
cortex O
( O
VMPFC O
) O
. O

METHODS O
: O
Two O
single-blinded O
, O
within-subject O
, O
active O
sham–controlled O
experiments O
were O
performed O
wherein O
neural O
reactivity O
to O
drug/alcohol O
cues O
versus O
neutral O
cues O
was O
evaluated O
immediately O
before O
and O
after O
receiving O
real O
or O
sham O
cTBS O
( O
110 O
% O
resting O
motor O
threshold O
, O
3600 O
pulses O
, O
Fp1 O
location O
; O
N= O
49 O
: O
25 O
cocaine O
users O
[ O
experiment O
1 O
] O
, O
24 O
alcohol O
users O
[ O
experiment O
2 O
] O
; O
196 O
total O
functional O
magnetic O
resonance O
imaging O
scans O
) O
. O

Generalized O
psychophysiological O
interaction O
and O
three-way O
repeated-measures O
analysis O
of O
variance O
were O
used O
to O
evaluate O
cTBS-induced O
changes O
in O
drug O
cue-associated O
functional O
connectivity O
between O
the O
left O
VMPFC O
and O
eight O
regions O
of O
interest O
: O
ventral O
striatum O
, O
left O
and O
right O
caudate O
, O
left O
and O
right O
putamen O
, O
left O
and O
right O
insula O
, O
and O
anterior O
cingulate O
cortex O
. O

RESULTS O
: O
In O
both O
experiments O
, O
there O
was O
a O
significant O
interaction O
between O
treatment O
( O
real/sham O
) O
and O
time O
( O
pre/post O
) O
. O

In O
both O
experiments O
, O
cue-related O
functional O
connectivity O
was O
significantly O
attenuated O
following O
real O
cTBS O
versus O
sham O
cTBS O
. O

There O
was O
no O
significant O
interaction O
with O
region O
of O
interest O
for O
either O
experiment O
. O

CONCLUSIONS O
: O
This O
is O
the O
first O
sham-controlled O
investigation O
to O
demonstrate O
, O
in O
two O
populations O
, O
that O
VMPFC O
cTBS O
can O
attenuate O
neural O
reactivity O
to O
drug O
and O
alcohol O
cues O
in O
frontostriatal O
circuits O
. O

These O
results O
provide O
an O
empirical O
foundation O
for O
future O
clinical O
trials O
that O
may O
evaluate O
the O
efficacy O
, O
durability O
, O
and O
clinical O
implications O
of O
VMPFC O
cTBS O
to O
treat O
addictions O
. O

METHODS O
AND O
MATERIALS O
Experiment O
1 O
( O
Cocaine O
Users O
) O
and O
Experiment O
2 O
( O
Heavy O
Alcohol O
Users O
) O
Participants O
. O

Non–treatment-seeking O
cocaine-dependent O
individuals O
( O
n O
= O
25 O
) O
and O
alcohol-dependent O
individuals O
( O
n O
= O
24 O
) O
were O
recruited O
from O
the O
Charleston O
, O
South O
Carolina O
, O
metropolitan O
area O
to O
participate O
in O
one O
of O
two O
single-blinded O
, O
active O
sham–controlled O
crossover O
studies O
. O

These O
studies O
were O
independent O
but O
were O
run O
in O
parallel O
by O
the O
same O
study O
coordinator O
using O
the O
same O
TMS O
equipment O
and O
facilities O
. O

Following O
informed O
consent O
procedures O
approved O
by O
the O
Medical O
University O
of O
South O
Carolina O
Institutional O
Review O
Board O
, O
participants O
completed O
screening O
assessments O
related O
to O
MRI O
and O
TMS O
protocol O
safety O
, O
mental O
status O
, O
and O
drug O
use O
to O
determine O
study O
eligibility O
( O
see O
Supplemental O
Methods O
for O
detailed O
inclusion/exclusion O
information O
) O
. O

Eligible O
participants O
completed O
two O
MRI/rTMS O
visits O
( O
each O
~1 O
hour O
) O
. O

Before O
each O
study O
session O
, O
a O
multipanel O
urine O
drug O
screen O
( O
QuikVue O
6-panel O
urine O
drug O
screen O
; O
Quidel O
, O
San O
Diego O
, O
CA O
) O
was O
given O
. O

Participants O
were O
told O
ahead O
of O
time O
that O
if O
they O
had O
positive O
urine O
drug O
screen O
for O
( O
meth O
) O
amphetamine O
, O
opiates O
, O
marijuana O
, O
or O
benzodiazepines O
they O
would O
not O
be O
eligible O
to O
participate O
on O
that O
day O
and O
that O
they O
would O
have O
one O
opportunity O
to O
reschedule O
. O

In O
this O
study O
, O
none O
of O
the O
participants O
had O
to O
reschedule O
for O
a O
positive O
urine O
drug O
screen O
. O

All O
participants O
received O
both O
real O
and O
sham O
VMPFC O
cTBS O
( O
one O
type O
per O
session O
) O
and O
were O
counterbalanced O
for O
the O
order O
in O
which O
they O
received O
stimulation O
( O
Fp1 O
landmark O
based O
on O
the O
International O
10–20 O
system O
; O
110 O
% O
resting O
motor O
threshold O
[ O
rMT O
] O
; O
six O
sessions O
of O
cTBS O
for O
each O
visit O
; O
3600 O
pulses O
total O
, O
with O
a O
60-second O
break O
after O
the O
first O
1800 O
pulses O
) O
. O

Visit O
2 O
occurred O
between O
7 O
and O
14 O
days O
after O
visit O
1. O
fMRI O
drug/alcohol O
cue O
reactivity O
task O
data O
were O
collected O
immediately O
before O
and O
after O
cTBS O
stimulation O
( O
Figure O
1 O
) O
, O
with O
the O
fMRI O
scan O
initiated O
within O
20 O
minutes O
of O
receiving O
real O
or O
sham O
cTBS O
and O
completed O
no O
later O
than O
40 O
minutes O
after O
cTBS O
to O
maximize O
presumed O
effects O
of O
cTBS O
on O
cortical O
activity O
. O

Self-reported O
cocaine O
or O
alcohol O
craving O
( O
respectively O
) O
was O
assessed O
at O
five O
time O
points O
: O
upon O
visit O
initiation O
, O
before O
the O
baseline O
fMRI O
scan O
, O
before O
the O
cTBS O
session O
, O
immediately O
after O
cTBS O
, O
and O
after O
the O
second O
fMRI O
scan O
. O

Procedures O
: O
Clinical O
Assessments O
. O

Self-report O
assessments O
included O
the O
Structured O
Clinical O
Interview O
for O
DSM-IV O
, O
Timeline O
Followback O
[ O
for O
cocaine O
, O
alcohol O
, O
marijuana O
, O
and O
nicotine O
] O
, O
Alcohol O
Use O
Disorders O
Identification O
Test O
, O
Fagerström O
Smoking O
Inventory O
, O
Beck O
Depression O
Inventory-II O
, O
and O
State-Trait O
Anxiety O
Inventory O
. O

Timeline O
Followback O
was O
used O
to O
evaluate O
past O
week O
’ O
s O
substance O
use O
at O
all O
study O
visits O
. O

As O
typically O
done O
in O
cue-induced O
craving O
studies O
, O
study O
personnel O
ensured O
that O
craving O
levels O
were O
at O
or O
below O
baseline O
before O
participants O
were O
dismissed O
from O
each O
visit O
. O

Procedures O
: O
Drug/Alcohol O
Cue O
Reactivity O
fMRI O
Task O
. O

The O
drug/alcohol O
cue O
reactivity O
task O
that O
has O
been O
used O
by O
our O
group O
in O
the O
past O
was O
administered O
in O
the O
MRI O
scanner O
as O
a O
block O
design O
using O
E-Prime O
2 O
software O
( O
Psychology O
Software O
Tools O
, O
Inc. O
, O
Sharpsburg O
, O
PA O
) O
. O

The O
total O
task O
time O
was O
12 O
minutes O
and O
consisted O
of O
six O
120-second O
epochs O
. O

Each O
epoch O
included O
alternating O
24-second O
blocks O
of O
four O
task O
conditions O
: O
drug O
, O
neutral O
, O
blur O
, O
and O
rest O
. O

Respectively O
, O
these O
task O
conditions O
included O
images O
of O
cocaine- O
or O
alcohol-related O
stimuli O
customized O
for O
each O
group O
( O
e.g. O
, O
crack O
pipe O
for O
cocaine O
users O
, O
liquor O
bottles O
for O
alcohol O
users O
) O
, O
neutral O
stimuli O
( O
e.g. O
, O
glass O
of O
water O
, O
cooking O
utensils O
, O
people O
eating O
dinner O
) O
, O
blurred O
stimuli O
acting O
as O
visual O
controls O
by O
matching O
substance O
images O
in O
color O
and O
hue O
, O
and O
a O
fixation O
cross O
for O
alert O
rest O
periods O
. O

During O
each O
task O
block O
, O
five O
images O
were O
presented O
( O
4.8 O
seconds O
) O
. O

Procedures O
: O
Neuroimaging O
Acquisition O
. O

Participants O
were O
scanned O
using O
a O
Siemens O
3.0T O
TIM O
Trio O
( O
Siemens O
Corp. O
, O
Erlangen O
, O
Germany O
) O
MRI O
scanner O
with O
a O
32-channel O
head O
coil O
. O

High-resolution O
T1-weighted O
structural O
images O
were O
acquired O
using O
a O
magnetization O
prepared O
rapid O
acquisition O
gradient-echo O
sequence O
( O
repetition O
time/echo O
time O
= O
1900 O
ms/2.34 O
ms O
; O
field O
of O
view O
= O
220 O
mm O
; O
matrix O
= O
256 O
× O
256 O
voxels O
; O
192 O
slices O
; O
slice O
thickness O
= O
1.0 O
mm O
with O
no O
gap O
; O
final O
resolution O
= O
1-mm3 O
voxels O
) O
. O

Functional O
images O
were O
acquired O
with O
a O
multislice O
gradient-echo O
echo-planar O
imaging O
( O
EPI O
) O
sequence O
( O
repetition O
time/echo O
time O
= O
2200 O
ms/35 O
ms O
; O
field O
of O
view O
= O
192 O
mm O
; O
matrix O
= O
64 O
× O
64 O
voxels O
; O
36 O
slices O
; O
slice O
thickness O
= O
3 O
mm O
with O
no O
gap O
; O
final O
resolution O
= O
3 O
mm3 O
voxels O
) O
. O

Each O
functional O
run O
consisted O
of O
328 O
time O
points O
. O

Procedures O
: O
cTBS O
Protocol—Real O
and O
Sham O
cTBS O
. O

Coil O
position O
was O
determined O
using O
standardized O
coordinates O
from O
the O
International O
10–20 O
system O
( O
with O
Fp1 O
corresponding O
to O
the O
left O
VMPFC O
stimulation O
target O
) O
. O

The O
location O
and O
orientation O
of O
each O
participant O
’ O
s O
coil O
placement O
was O
indicated O
on O
a O
nylon O
cap O
that O
participants O
wore O
throughout O
visit O
1 O
and O
both O
MRI/rTMS O
sessions O
. O

Participants O
’ O
rMT O
was O
identified O
via O
the O
standardized O
Parametric O
Estimation O
by O
Sequential O
Testing O
procedure O
. O

The O
cTBS O
was O
administered O
with O
a O
figure-of-eight O
Cool-B65 O
A/P O
coil O
( O
MagVenture O
, O
Farum O
, O
Denmark O
) O
. O

Participants O
received O
two O
2-minute O
trains O
of O
cTBS O
over O
Fp1 O
( O
one O
train O
= O
120 O
seconds O
; O
three O
pulse O
bursts O
at O
5 O
Hz O
; O
15 O
pulses/s O
; O
1800 O
pulses/train O
; O
60-second O
intertrain O
interval O
; O
110 O
% O
rMT O
) O
( O
see O
Supplemental O
Methods O
for O
details O
of O
rigorous O
active O
sham O
) O
. O

To O
enhance O
tolerability O
, O
stimulation O
intensity O
was O
gradually O
escalated O
in O
5 O
% O
increments O
( O
from O
80 O
% O
to O
110 O
% O
rMT O
) O
over O
the O
first O
30 O
seconds O
of O
each O
train O
. O

Procedures O
: O
Cue O
Recollection O
During O
cTBS O
Administration O
. O

Before O
cTBS O
administration O
, O
participants O
were O
asked O
to O
recall O
the O
last O
time O
they O
used O
cocaine O
or O
alcohol O
( O
respectively O
) O
and O
, O
using O
a O
series O
of O
standardized O
questions O
from O
traditional O
Narrative O
Exposure O
Therapy O
practice O
, O
they O
were O
asked O
to O
describe O
the O
place O
they O
were O
using O
, O
a O
visual O
description O
of O
the O
scene O
, O
and O
a O
description O
of O
the O
sensory O
properties O
of O
the O
drug O
including O
taste O
, O
smell O
, O
and O
sensation O
. O

During O
cTBS O
administration O
, O
the O
participants O
were O
primed O
every O
20 O
seconds O
to O
“ O
Think O
about O
that O
scene O
you O
described O
wherein O
you O
were O
last O
using O
cocaine/alcohol O
” O
( O
paraphrased O
so O
as O
to O
be O
tailored O
to O
the O
participant O
’ O
s O
description O
) O
. O

Data O
Analysis O
Self-reported O
Craving O
. O

Self-reported O
craving O
scores O
were O
entered O
into O
a O
two-way O
analysis O
of O
variance O
( O
ANOVA O
) O
( O
treatment O
type O
[ O
real/sham O
] O
× O
time O
[ O
pre/post O
] O
) O
and O
subsequent O
t O
tests O
to O
determine O
the O
effect O
of O
treatment O
on O
changes O
in O
craving O
. O

Neuroimaging O
Preprocessing O
. O

MRI O
data O
were O
preprocessed O
using O
standard O
protocols O
via O
SPM12 O
( O
Wellcome O
Department O
of O
Cognitive O
Neurology O
, O
London O
, O
United O
Kingdom O
) O
implemented O
in O
MATLAB O
7.14 O
( O
The O
MathWorks O
, O
Inc. O
, O
Natick O
, O
MA O
) O
( O
see O
Supplemental O
Methods O
for O
preprocessing O
details O
) O
. O

Data O
analyses O
were O
conducted O
on O
a O
total O
of O
49 O
participants O
( O
30 O
men O
; O
mean O
age O
= O
34 O
± O
11 O
years O
; O
age O
range O
= O
21–54 O
years O
) O
( O
see O
Table O
1 O
for O
detailed O
demographics O
) O
. O

Generalized O
Psychophysiological O
Interaction O
. O

Generalized O
psychophysiological O
interaction O
( O
gPPI O
) O
was O
used O
to O
investigate O
task-modulated O
patterns O
of O
FC O
between O
the O
VMPFC O
and O
eight O
regions O
of O
interest O
( O
ROIs O
) O
during O
the O
drug/alcohol O
cue O
reactivity O
task O
. O

gPPI O
was O
conducted O
as O
described O
by O
McLaren O
et O
al O
. O

( O
see O
Supplemental O
Methods O
for O
gPPI O
analysis O
details O
) O
. O

We O
computed O
drug/alcohol O
cue O
minus O
neutral O
cue O
“ O
contrast O
betas O
” O
indicating O
the O
relative O
FC O
during O
drug O
versus O
neutral O
conditions O
. O

Four O
contrast O
betas O
were O
computed O
: O
prereal O
cTBS O
, O
postreal O
cTBS O
, O
presham O
, O
and O
postsham O
. O

We O
aimed O
to O
show O
that O
FC O
between O
the O
VMPFC O
and O
several O
striatal O
and O
salience O
regions O
would O
decrease O
during O
drug/alcohol O
cue O
versus O
neutral O
cue O
exposure O
following O
real O
but O
not O
sham O
VMPFC O
cTBS O
. O

To O
do O
this O
, O
we O
conducted O
a O
three-way O
repeated-measures O
ANOVA O
involving O
treatment O
type O
( O
real O
vs. O
sham O
) O
, O
time O
( O
pre O
vs. O
post O
) O
, O
and O
ROI O
as O
independent O
variables O
and O
drug/alcohol O
versus O
neutral O
contrast O
betas O
as O
the O
dependent O
variable O
. O

Subsequent O
t O
tests O
were O
then O
used O
to O
determine O
the O
effect O
of O
treatment O
on O
changes O
in O
drug/alcohol O
cue–evoked O
FC O
across O
regions O
. O

The O
focus O
on O
FC O
analysis O
in O
the O
present O
study O
, O
rather O
than O
traditional O
general O
linear O
model O
analysis O
, O
was O
due O
to O
the O
nature O
of O
TMS O
effects O
on O
the O
brain O
. O

To O
influence O
subcortical O
brain O
regions O
( O
such O
as O
the O
striatum O
) O
, O
we O
applied O
TMS O
to O
cortical O
targets O
( O
such O
as O
the O
VMPFC O
) O
and O
took O
advantage O
of O
the O
monosynaptic O
functional O
connections O
between O
cortical O
and O
subcortical O
regions O
. O

As O
such O
, O
we O
felt O
that O
measuring O
the O
efficacy O
of O
the O
cTBS-induced O
changes O
in O
frontostriatolimbic O
circuits O
should O
be O
conducted O
at O
the O
level O
of O
these O
functional O
connections O
. O

Relationship O
Between O
Clinical/Demographic O
Variables O
and O
FC O
Changes O
. O

To O
determine O
whether O
clinical O
and O
demographic O
variables O
influenced O
or O
predicted O
cTBS O
treatment O
outcomes O
, O
hierarchical O
multiple O
linear O
regressions O
were O
conducted O
with O
clinical O
and O
demographic O
variables O
of O
interest O
as O
the O
predictors O
and O
covariate O
predictors O
and O
changes O
in O
VMPFC O
FC O
after O
real O
versus O
sham O
cTBS O
as O
the O
outcome O
variable O
. O

Scalp-to-Cortex O
Distance O
Measurement O
. O

Given O
that O
the O
effects O
of O
TMS O
on O
cortical O
depolarization O
are O
proportional O
to O
the O
distance O
between O
the O
skull O
and O
cortex O
, O
we O
calculated O
the O
distance O
from O
the O
scalp O
to O
cortex O
on O
the O
transverse O
plane O
of O
magnetization O
prepared O
rapid O
acquisition O
gradient-echo O
images O
for O
each O
participant O
using O
BrainRuler O
software O
, O
a O
dedicated O
tool O
for O
scalp-to-cortex O
distance O
measurements O
. O

The O
average O
distance O
from O
participant-specific O
placement O
of O
Fp1 O
to O
the O
cortex O
was O
17.4 O
± O
3.7 O
mm O
for O
cocaine O
users O
and O
16.4 O
± O
3.2 O
mm O
for O
alcohol O
users O
. O

These O
distances O
were O
incorporated O
into O
the O
analyses O
as O
covariates O
. O

